المؤلفون: Pett, S. L., Amin, J., Horban, A., Andrade-Villanueva, J., Losso, M., Porteiro, N., Madero, J. S., Belloso, W., Tu, E., Silk, D., Kelleher, A., Harrigan, R., Clark, A., Sugiura, W., Wolff, M., Gill, J., Gatell, J., Clarke, A., Ruxrungtham, K., Prazuck, T., Kaiser, R., Woolley, I., Alberto Arnaiz, J., Cooper, D., Rockstroh, J. K., Mallon, P., Emery, S., Amin, Janaki, Belloso, Waldo, Clark, Andrew, Clarke, Amanda

مصطلحات موضوعية: HIV-1, Maraviroc, Protease inhibitor, Switch, 2719 Health Policy, 2725 Infectious Diseases, 2736 Pharmacology (medical)

الإتاحة: https://doi.org/10.1111/hiv.12532Test
https://espace.library.uq.edu.au/view/UQ:705380Test

المؤلفون: Pett, Sarah Lilian, Amin, Janaki, Horban, Andrejz, Andrade-Villanueva, Jaime, Losso, Marcelo, Porteiro, Norma, Sierra Madero, Juan, Belloso, Waldo, Tu, Elise, Silk, David, Kelleher, Anthony, Harrigan, Richard, Clark, Andrew, Sugiura, Wataru, Wolff, Marcelo, Gill, John, Gatell, Jose, Fisher, Martin, Clarke, Amanda, Ruxrungtham, Kiat, Prazuck, Thierry, Kaiser, Rolf, Woolley, Ian, Alberto Arnaiz, Juan, Cooper, David, Rockstroh, Jurgen K., Mallon, Patrick, Emery, Sean

مصطلحات موضوعية: Antiretroviral, Comorbidity, HIV-1, Maraviroc, Switch, 2725 Infectious Diseases, 2726 Microbiology (medical)

العلاقة: orcid:0000-0001-6072-8309; Not set; 15H04740

الإتاحة: https://doi.org/10.1093/cid/ciw207Test
https://espace.library.uq.edu.au/view/UQ:512383Test

المؤلفون: Pett, Sarah Lilian, Amin, Janaki, Horban, Andrejz, Andrade-Villanueva, Jaime, Losso, Marcelo, Porteiro, Norma, Sierra Madero, Juan, Belloso, Waldo, Tu, Elise, Silk, David, Kelleher, Anthony, Harrigan, Richard, Clark, Andrew, Sugiura, Wataru, Wolff, Marcelo, Gill, John, Gatell, Jose, Fisher, Martin, Clarke, Amanda, Ruxrungtham, Kiat, Prazuck, Thierry, Kaiser, Rolf, Woolley, Ian, Arnaiz, Juan Alberto, Cooper, David, Rockstroh, Jürgen K, Mallon, Patrick, Emery, Sean, for the Maraviroc Switch (MARCH) Study Group

المصدر: Pett, SL, Amin, J, Horban, A, Andrade-Villanueva, J, Losso, M, Porteiro, N, Sierra Madero, J, Belloso, W, Tu, E, Silk, D, Kelleher, A, Harrigan, R, Clark, A, Sugiura, W, Wolff, M, Gill, J, Gatell, J, Fisher, M, Clarke, A, Ruxrungtham, K, Prazuck, T, Kaiser, R, Woolley, I, Arnaiz, JA, Cooper, D, Rockstroh, JK, Mallon, P, Emery, S, for the Maraviroc Switch (MARCH) Study Group, , (2016). Maraviroc, as a switch option, in HIV-1–infected individuals with stable, well-controlled HIV replication and R5-tropic virus on their first nucleoside/nucleotide reverse transcriptase inhibitor plusrRitonavir-boosted protease inhibitor regimen: Week 48 results of the randomized, ....

مصطلحات موضوعية: Maraviroc, Switch, HIV-1, Anteretroviral, Comorbidity, 111502 Clinical Pharmacology and Therapeutics

العلاقة: Clinical Infectious Diseases, 2016, Vol. 63, No. 1, p. 122-132; http://hdl.cqu.edu.au/10018/1318492Test; cqu:19274; http://dx.doi.org/10.1093/cid/ciw207Test; eISSN:1537-6591

الإتاحة: https://doi.org/10.1093/cid/ciw207Test
http://hdl.cqu.edu.au/10018/1318492Test